Skip to main content
. Author manuscript; available in PMC: 2020 Feb 1.
Published in final edited form as: Psychopharmacology (Berl). 2018 Nov 17;236(2):821–830. doi: 10.1007/s00213-018-5118-y

Fig. 5.

Fig. 5

LY379268 reversal of PCP-induced hyperlocomotion in mice treated chronically with vehicle (A) or LY379268 (B). (A) Locomotor activity (distance traveled) in mice after chronic treatment with saline. (B) Locomotor activity (distance traveled) in mice after chronic treatment with LY379268. Data are presented as group means±SEM for 20-min time blocks. *p<0.05, significantly different from VEH – PCP group.